Top 10 Dermatology Articles of 2023

1. FDA Gives the Green Light for Cheek Wrinkle Solution

Galderma announced the approval of an injectable poly-L-lactic acid to correct fine lines and wrinkles.

2. When to Call a Time Out on Mohs Surgery

Jerry Brewer, MD, MS, shared pearls on reasons to avoid or discontinue Mohs surgery and keeping calm with stressed, vulnerable patients.

3. The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

Mona Shahriari, MD, discusses what dermatologists and patients with atopic dermatitis can expect as we transition from winter to spring, as well as new and emerging treatments and technologies for managing atopic dermatitis that she’s looking ahead to as the year progresses.

4. FDA Approves Skinvive by Juvederm for Improving Skin Smoothness

Previous research demonstrated the microdroplet injection’s ability to improve skin quality, smoothness, and overall hydration.

5. Proposed FDA Ban of Formaldehyde in Hair Relaxers: What Comes Next?

Christopher Bunick, MD, PhD, and David Light, CEO of Valisure, weigh in on the proposed formaldehyde ban.

6. FDA Clears Brella SweatControl Patch for Reduced Primary Axillary Hyperhidrosis

Patients can achieve reduced excessive underarm sweating after one in-office treatment.

7. Gut Health and Its Impact on the Skin

The gut-brain-skin axis is more important to overall health than previously understood, and prebiotics and probiotics play a large role in the benefits.

8. Discovering Dermatology Times: August 2023 Acne Vulgaris Supplement

Learn more about the in-depth topics covered in the August 2023 Frontline Forum acne vulgaris supplement of Dermatology Times.

9. Raj Chovatiya, MD, PhD, Discusses All Things Inflammatory Diseases at AAD 2023

With the recent therapeutic revolution, there has never been a better time to find the right treatment option for your patient suffering from inflammatory diseases.

10. Investigating Links Between Cancer and Psoriasis Management

Because of the chronic inflammatory state of psoriasis and the immunosuppression produced by some systemic medications, patients with psoriasis may have an increased risk of lymphoma and nonmelanoma skin cancer.

What was your favorite news from 2023? Email us at DTEditor@mmhgroup.com.